Such drawbacks are why a pill to alleviate sickle-cell, if developed, could sweep CRISPR from the playing field. A pill version could also resolve a brewing...
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Vertex developed a CRISPR...
The patent on CRISPR has been the fulcrum off a decade-long legal fight after the Broad Institute, a research center in Cambridge, Massachusetts, snatched rights to...
The news: A new robot training model, dubbed “KnowNo,” aims to teach robots to ask for our help when orders are unclear. At the same time,...
The association technique hasn’t always paid off—but starting in 2007 the gene searches hit pay dirt for sickle-cell. In one study, for instance, a team in...
And really, what’s the point of such a hard-won triumph unless it’s to enforce your rights? “Honestly, this train has been coming down the track since at...
Vaccine makers have also struggled because HIV kills the very immune cells meant to stop infection. But a decade ago, Khalili says, he realized that CRISPR...
I watched scientists, ethicists, patient advocacy groups, and others wrestle with these topics at the Third International Summit on Human Genome Editing in London earlier this...
Meredith Broussard is unusually well placed to dissect the ongoing hype around AI. She’s a data scientist and associate professor at New York University, and she’s...
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Sam Altman invested $180...